A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive HCM)
ClinicalTrials.gov NCT05489705
Research payments
$2,410,895
Through program year 2024, $2,410,895 in research payments was reported against A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive HCM), across 135 payments, paid by E.R. Squibb & Sons, L.L.C..
- Paid by
- E.R. Squibb & Sons, L.L.C.
- ClinicalTrials.gov
- NCT05489705
By program year
3 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | Research | $836,356 | 54 |
| 2023 | Research | $1,437,755 | 59 |
| 2022 | Research | $136,784 | 22 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Mariko Harper Federal Way, WA Named on 3 payments
- Mark Zenker Nashville, TN Named on 3 payments
- Albree Tower-Rader Boston, MA Named on 3 payments
- Gregory Koshkarian Tucson, AZ Named on 3 payments
- Johanna Contreras New York, NY Named on 3 payments
- Anene Ukaigwe Cleveland, OH Named on 2 payments
- Vinh Nguyen Temple, TX Named on 2 payments
- Judy Wang Sarasota, FL Named on 2 payments
- Christopher Bianco Morgantown, WV Named on 2 payments
- Karthikeyan Ananthasubramaniam West Bloomfield, MI Named on 2 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.